Home / Products / Peptides / Details
video
Customized Cagrilintide 5mg+Semaglutide 5mg

Customized Cagrilintide 5mg+Semaglutide 5mg

Minimum Order Quantity: 10 bottles/set Origin: Shenzhen, China Shipping Time: Approx. 10-15 days Accepted Payment Methods: Bitcoin/USDT/Bank Transfer/Western Union

Product Introduction

 

 

I. Product Overview

 

This is a long-acting, dual-target injection that combines cangrilintide (a long-acting amylin analog) and semaglutide (a GLP-1 receptor agonist) in a 1:1 ratio (5mg each). It is specifically designed for powerful weight control and stable blood sugar metabolism, requiring only one subcutaneous injection per week, catering to the needs of modern individuals who want efficient management of their physique and health while avoiding inconvenience.

 

 

 

887

 

 

 

II. Core Parameters

 

Ingredient Ratio: Cagrilintide 5mg + Semaglutide 5mg (per bottle/vial)

Dosage Form: Sterile lyophilized powder (to be dissolved in a special solvent before injection)

Routine of Administration: Subcutaneous injection (abdomen/thigh/upper arm, avoiding blood vessels)

Frequency: Once a week, at a fixed time, no need for daily administration

Half-Life: Both are long-acting, with an action time of up to 7 days in the body and stable blood drug concentrations

Specifications: Commonly 10 bottles/box, 10mg per bottle (5mg + 5mg)

 

 

 

III. Core Functions


Powerful appetite suppression, controlling cravings at the source
Caglioglutide inhibits hunger signals in the brain, while cagrilintide replenishes the body's satiety hormones, doubly blocking the urge to eat, especially significantly reducing cravings for high-calorie foods, sweets, and late-night snacks, eliminating the need for willpower.

 

Prolonged satiety, feeling full after eating only a little: Slows gastric emptying, providing a feeling of fullness even after eating small amounts of food, naturally reducing food intake at each meal and preventing unknowingly overeating, gradually cultivating a smaller appetite habit.

 

Stable blood sugar control, smoother metabolism: Promotes on-demand insulin secretion and inhibits glycemic hormones, preventing post-meal blood sugar spikes, suitable for people with high blood sugar or prediabetes, controlling weight while protecting metabolism.

 

Sustained fat burning and weight loss, less prone to rebound: Dual-target synergistic effect, 68-week clinical data shows an average weight loss of over 20%, far superior to monotherapy; and less prone to weight loss plateaus, fat loss is steady, not short-term dehydration.

 

 

acd9a9624786d62a65903e517a7196c3 1

 

 

 

 

IV. Core Advantages

 

Outperforms monotherapy, 1+1>2: Weight loss effect is improved by approximately 7% compared to using semaglutide alone, with nearly 40% of adults experiencing a weight loss of over 25%, a level rarely achieved with monotherapy.

 

Once a week, convenient and effortless: No daily check-in, no frequent injections, suitable for busy working professionals and those who dislike hassle, less likely to miss injections, low discontinuation rate.

 

Weight Control + Blood Sugar Stabilization: A Two-Pronged Approach

Not only does it help you lose weight, but it also improves insulin resistance, making it suitable for obese individuals with metabolic syndrome accompanied by high blood sugar, high cholesterol, and high blood pressure. It addresses multiple issues at once.

Low Rebound Rate, Healthier Weight Loss

 

It reduces fat, not water weight, so your skin is less likely to sag. Simultaneously, it regulates metabolic hormones, so as long as you maintain a normal diet and lifestyle after stopping the medication, you are less likely to regain weight quickly.

Sufficient Dosage, More Stable Effect

 

The commonly used clinical dosage is 2.4mg + 2.4mg. This product uses a high dose of 5mg + 5mg, suitable for individuals with a high starting weight or those who do not respond well to single-drug therapy. It has a faster onset and more potent effect.

 

 

 

159

 

 

 

V. Disadvantages and Real-World Experiences

 

Significant Initial Gastrointestinal Reactions (Most Common)

Nausea, bloating, constipation, and mild vomiting are common in the first 2-4 weeks. Not everyone experiences these; most are mild to moderate and will gradually disappear as the body adapts. A few people experience severe reactions and need to reduce the dosage or stop the treatment.

 

Mild discomfort at the injection site: Subcutaneous injections may cause mild redness, swelling, itching, and induration, which can be relieved by applying heat. Long-term injections at the same site may lead to fat hyperplasia; changing the injection site each time can avoid this.

 

High price, long-term cost pressure: High-dose compound preparations are expensive per box, and long-term use requires a certain budget; however, compared to monotherapy plus other blood sugar/fat-control products, the cost-effectiveness is actually higher.

 

Risk of hypoglycemia (rare but requires attention): The risk of hypoglycemia with monotherapy is extremely low, but when used in combination with hypoglycemic drugs or when food intake is insufficient, palpitations, tremors, and dizziness may occur; this can be avoided by maintaining a normal diet and not increasing the dosage without authorization.

 

Many contraindications, not suitable for everyone: Those with a history/family history of medullary thyroid carcinoma, type 2 multiple endocrine neoplasia, allergies, pregnant/lactating women, those with severe liver or kidney disease, or those with a history of pancreatitis should absolutely not use this product.

 

 

 

 

VI. Applicable Scenarios

 

**Severe Obesity / High Starting Weight Loss:** Individuals with a BMI ≥ 30, or BMI ≥ 27 with metabolic issues, experiencing poor weight loss with single-drug therapy and prone to plateaus, seeking rapid and stable weight loss.

 

**Obesity with Abnormal Blood Sugar:** Individuals with type 2 diabetes, prediabetes, or insulin resistance who want to lose weight while controlling blood sugar, but avoid multiple medications and the hassle.

 

**Stubborn Obesity / Prone to Rebound Weight Loss:** Individuals who have tried dieting, exercise, and single-drug therapy, experiencing slow weight loss and prone to rebound, seeking hormonal regulation to develop a lean physique.

 

**Busy Individuals / Those Who Want to Control Weight Without the Hassle:** Office workers, stay-at-home mothers, frequent travelers, those with limited time for exercise, and those who dislike daily medication/injections, seeking an efficient and hassle-free method for weight control.

 

**Metabolic Syndrome Individuals:** Individuals with obesity + hypertension + hyperlipidemia + fatty liver, seeking to address multiple metabolic issues at once and reduce the number of medications required.


**Impactful Individuals:** Individuals with obesity + hypertension + hyperlipidemia + fatty liver, seeking to address multiple metabolic issues at once and reduce the number of medications required.

 

 

 

VII. Precautions


Strictly adhere to the dosage; do not increase the dosage without authorization.
Administer once a week, one vial (5mg + 5mg) each time. Do not increase the dosage for faster weight loss, as this may worsen gastrointestinal reactions and increase risks. A small dose can be used initially for transition.

 

Dietary Recommendations: Light, High-Protein, Low-Sugar
Eat less sweets, fried foods, and high-carbohydrate foods. Eat more eggs, lean meat, and vegetables to reduce the burden on the digestive system and protect muscle mass for a more toned physique. Do not diet excessively.

 

Injection Details: Change Injection Sites, Prevent Infection
Choose different injection sites such as the abdomen, thigh, and upper arm each time, avoiding areas of redness/swelling. Disinfect the injection site before use; discard the needle after use and do not reuse it.

 

Monitor Body Reactions and Adjust Accordingly
Initial nausea and bloating can be relieved by drinking plenty of water and taking probiotics. If vomiting persists, severe diarrhea occurs, or severe abdominal pain develops, discontinue use immediately and seek medical attention. Regularly check blood sugar and thyroid function.

 

Do not use concurrently with similar or potent hypoglycemic agents.
Avoid simultaneous use with GLP-1 inhibitors such as semaglutide and liraglutide; when used with metformin, follow your doctor's instructions to prevent hypoglycemia.

 

Long-term use requires regular checkups.
Check liver and kidney function, blood lipids, and thyroid function every 3-6 months to ensure medication safety; after achieving weight loss goals, reduce the dosage as directed by your doctor to maintain the weight and prevent rebound.

Hot Tags: customized cagrilintide 5mg+semaglutide 5mg, China customized cagrilintide 5mg+semaglutide 5mg manufacturers, suppliers, factory

Send Inquiry

whatsapp

Phone

E-mail

Inquiry

Bag